Bioinformatics researchers have developed a new, quicker way to sequence monoclonal antibodies — a process that is many times faster than the sequencing technology typically used by academic and industry researchers today.
Bioinformatics researchers have developed a new, quicker way to sequence monoclonal antibodies — a process that is many times faster than the sequencing technology typically used by academic and industry researchers today.